Related Experiment Video
Updated: Jun 3, 2025
06:32
Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts
Published on: April 13, 2022
1.7K
Targeting Asparagine Metabolism in Solid Tumors.
Keita Hanada1,2, Kenji Kawada1,3, Kazutaka Obama1
1Department of Gastrointestinal Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Nutrients
|January 11, 2025
Summary
Cancer cells reprogram energy metabolism to fuel growth, with asparagine metabolism emerging as a key therapeutic target. While effective in leukemia, asparagine restriction shows limited efficacy in solid tumors due to cellular reprogramming.
Area of Science:
- Oncology
- Metabolic pathways
- Cancer biology
Background:
- Cancer cells exhibit altered energy metabolism to support rapid growth and proliferation.
- Metabolic reprogramming is a recognized hallmark of cancer, presenting therapeutic vulnerabilities.
- Asparagine metabolism is increasingly recognized for its critical role in cancer cell survival and tumor development.
Purpose of the Study:
- To provide a comprehensive review of asparagine metabolism in various cancers.
- To highlight the physiological significance of asparagine in tumorigenesis.
- To discuss strategies for improving therapeutic outcomes and overcoming resistance to asparagine-targeted therapies.
Main Methods:
- Literature review of studies on cancer metabolism and asparagine.
- Analysis of the role of asparagine in nutrient production and cancer cell growth.
- Examination of therapeutic approaches targeting asparagine metabolism.
Main Results:
- Asparagine is essential for synthesizing other nutrients crucial for tumor growth.
- Nutritional inhibition of asparagine has shown success in treating leukemia.
- Solid tumors exhibit reprogramming mechanisms that limit the efficacy of asparagine restriction alone.
Conclusions:
- Asparagine metabolism is a vital process in cancer development and progression.
- Targeting asparagine offers a promising avenue for cancer therapy, particularly when combined with strategies to overcome resistance.
- Further research into asparagine metabolism is crucial for developing effective treatments for solid tumors.
Related Concept Videos
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:19Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K